These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14983741)

  • 21. Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery.
    Hopman WP; Houben PG; Speth PA; Lamers CB
    Gut; 1988 Jul; 29(7):930-4. PubMed ID: 2840365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial.
    Horvath A; Dziechciarz P; Szajewska H
    World J Gastroenterol; 2013 May; 19(20):3062-8. PubMed ID: 23716985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of a soluble dietary fiber from Amorphophallus konjac on cytotoxicity and DNA damage induced by fecal water in Caco-2 cells.
    Yeh SL; Lin MS; Chen HL
    Planta Med; 2007 Oct; 73(13):1384-8. PubMed ID: 17893827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal and spatial regulation of glucomannan deposition and mobilization in corms of Amorphophallus konjac (Araceae).
    Chua M; Hocking TJ; Chan K; Baldwin TC
    Am J Bot; 2013 Feb; 100(2):337-45. PubMed ID: 23347975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of glucomannan isolated from fresh tuber of Porang (Amorphophallus muelleri Blume).
    Yanuriati A; Marseno DW; Rochmadi ; Harmayani E
    Carbohydr Polym; 2017 Jan; 156():56-63. PubMed ID: 27842852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of highly purified glucomannan-based fibers in childhood obesity].
    Livieri C; Novazi F; Lorini R
    Pediatr Med Chir; 1992; 14(2):195-8. PubMed ID: 1324483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physico-chemical properties related to gastrointestinal function of 6 sources of dietary fiber].
    Rosado JL; Díaz M
    Rev Invest Clin; 1995; 47(4):283-9. PubMed ID: 8525130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of the integration of a habitual diet with glucomannan fiber in hypercholesterolemia. A clinical study in familial and sporadic hyperlipoproteinemia with lipo-proteic phenotype IIa and IIb].
    Fanelli V; Angelico F; Stefanutti C; Calvieri A; Fazio S
    Clin Ter; 1986 Oct; 119(1):17-23. PubMed ID: 3024902
    [No Abstract]   [Full Text] [Related]  

  • 29. [The importance of guar for the treatment of gastroenterologic diseases].
    Schrezenmeir J; Kasper H
    Beitr Infusionther Klin Ernahr; 1983; 12():111-26. PubMed ID: 6316906
    [No Abstract]   [Full Text] [Related]  

  • 30. Dumping syndrome in children. Diagnosis and effect of glucomannan on glucose tolerance and absorption.
    Kneepkens CM; Fernandes J; Vonk RJ
    Acta Paediatr Scand; 1988 Mar; 77(2):279-86. PubMed ID: 2833060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan.
    Marzio L; Del Bianco R; Donne MD; Pieramico O; Cuccurullo F
    Am J Gastroenterol; 1989 Aug; 84(8):888-91. PubMed ID: 2547312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of konjac glucomannan by enzymes in human feces and formation of short-chain fatty acids by intestinal anaerobic bacteria.
    Matsuura Y
    J Nutr Sci Vitaminol (Tokyo); 1998 Jun; 44(3):423-36. PubMed ID: 9742462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial health characteristics of native and hydrolysed konjac (Amorphophallus konjac) glucomannan.
    Tester RF; Al-Ghazzewi FH
    J Sci Food Agric; 2016 Aug; 96(10):3283-91. PubMed ID: 26676961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of konjac glucomannan degrading enzyme from anaerobic human intestinal bacterium, Clostridium butyricum-Clostridium beijerinckii group.
    Nakajima N; Matsuura Y
    Biosci Biotechnol Biochem; 1997 Oct; 61(10):1739-42. PubMed ID: 9362121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man.
    Shima K; Tanaka A; Ikegami H; Tabata M; Sawazaki N; Kumahara Y
    Horm Metab Res; 1983 Jan; 15(1):1-3. PubMed ID: 6299917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome.
    Giannini EG; Mansi C; Dulbecco P; Savarino V
    Nutrition; 2006 Mar; 22(3):334-42. PubMed ID: 16413751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].
    Cairella M; Marchini G
    Clin Ter; 1995 Apr; 146(4):269-74. PubMed ID: 7796558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in symptoms after proximal selective vagotomy through increased dietary viscosity.
    Harju E; Mäkelä J
    Am J Gastroenterol; 1984 Nov; 79(11):861-3. PubMed ID: 6095650
    [No Abstract]   [Full Text] [Related]  

  • 39. A new immunomodulatory function of low-viscous konjac glucomannan with a small particle size: its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice.
    Onishi N; Kawamoto S; Nishimura M; Nakano T; Aki T; Shigeta S; Shimizu H; Hashimoto K; Ono K
    Int Arch Allergy Immunol; 2005 Mar; 136(3):258-65. PubMed ID: 15722635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Konjac glucomannan and konjac glucomannan/xanthan gum mixtures as excipients for controlled drug delivery systems. Diffusion of small drugs.
    Alvarez-Manceñido F; Landin M; Lacik I; Martínez-Pacheco R
    Int J Pharm; 2008 Feb; 349(1-2):11-8. PubMed ID: 17804182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.